Pfizer agrees to manufacture Gilead's coronavirus drug remdesivir
Pfizer has agreed to manufacture and supply Gilead Sciences’ antiviral drug remdesivir. The multiyear agreement will support efforts to scale up the supply of the intravenous drug. Pfizer will manufacture the drug at its McPherson, Kansas, facility.
View the full story here: https://www.cnbc.com/2020/08/07/pfizer-agrees-to-manufacture-gileads-coronavirus-drug-remdesivir.html
